Drug Development Pipeline

Our pipeline has been developed under FDA’s streamlined 505(b)2 regulatory pathway allowing us to leverage existing preclinical safety data across multiple investigational products and indications and in some cases enter directly into clinical trials to further evaluate safety and preliminary efficacy.

Follow Us

(817) 900-4002
3909 Hulen Street
Fort Worth, Texas 76107